Katerina Slanska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katerina Slanska has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Hana Faldynova
Masaryk University
1 shared publication - Jan Velecky
Loschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University , Kamenice 753/5, Brno 625 00
1 shared publication - Jiri Damborsky
Loschmidt Laboratories Department of Experimental Biology and RECETOX Faculty of Science Masaryk University Brno Czech Republic
1 shared publication - Mark Dörr
Department of Biotechnology & Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, Greifswald, Germany
1 shared publication Nela Sendlerova
Loschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
1 shared publication- Pedro Hermosilla
TU Wien, Institute of Visual Computing and Human‐Centered Technology Vienna Austria
1 shared publication
Latest Publications
- Open Access
SoluProtMut: Siamese Deep Learning for Predicting Solubility Effects of Protein Mutations with Experimental Validation
Protein solubility is an attractive engineering target because it is a critical property influencing the scalability of protein production and the success of therapeutic proteins in biomedical applications. However, predicting in silico solubility changes upon mutation is challenging due to data heterogeneity and protein bias. Here, we explore how different sources of solubility data can be used for machine learning and present SoluProtMut, a Siamese deep geometric neural network trained to predict the impact of mutations on protein solubility. Our final model was trained exclusively on deep mutational scanning data derived from recombinant protein expression assays in bacterial and yeast systems. We compare our model with five established solubility prediction methods. On an independent set of 44 proteins, the model achieves the highest informedness among the methods compared, with the largest margin for multipoint mutations (a ternary informedness of 26.5%, 8.8 percentage points above the next-best method). Our findings also reaffirm that the scarcity of solubility data continues to hamper progress in this field. To address this limitation, we experimentally quantified solubility changes for 277 single-point and multipoint mutants of haloalkane dehalogenase. Complemented by recent deep-mutational-scanning data on myoglobin, we employed both datasets for external validation. We identify protein-level generalization, rather than model capacity or training-set size, as the main limiting factor in the domain. Integrating high-throughput assays with deep learning nonetheless offers a route to improving the accuracy and scope of solubility prediction. Abstract Figure:
Open AccessSoluProtMut: Siamese Deep Learning for Predicting Solubility Effects of Protein Mutations with Experimental Validation
Protein solubility is an attractive engineering target because it is a critical property influencing the scalability of protein production and the success of therapeutic proteins in biomedical applications. However, predicting in silico solubility changes upon mutation is challenging due to data heterogeneity and protein bias. Here, we explore how different sources of solubility data can be used for machine learning and present SoluProtMut, a Siamese deep geometric neural network trained to predict the impact of mutations on protein solubility. Our final model was trained exclusively on deep mutational scanning data derived from recombinant protein expression assays in bacterial and yeast systems. We compare our model with five established solubility prediction methods. On an independent set of 44 proteins, the model achieves the highest informedness among the methods compared, with the largest margin for multipoint mutations (a ternary informedness of 26.5%, 8.8 percentage points above the next-best method). Our findings also reaffirm that the scarcity of solubility data continues to hamper progress in this field. To address this limitation, we experimentally quantified solubility changes for 277 single-point and multipoint mutants of haloalkane dehalogenase. Complemented by recent deep-mutational-scanning data on myoglobin, we employed both datasets for external validation. We identify protein-level generalization, rather than model capacity or training-set size, as the main limiting factor in the domain. Integrating high-throughput assays with deep learning nonetheless offers a route to improving the accuracy and scope of solubility prediction. Abstract Figure: